MC1536A1 - Nouvelles phenethanolamines - Google Patents

Nouvelles phenethanolamines

Info

Publication number
MC1536A1
MC1536A1 MC831652A MC1652A MC1536A1 MC 1536 A1 MC1536 A1 MC 1536A1 MC 831652 A MC831652 A MC 831652A MC 1652 A MC1652 A MC 1652A MC 1536 A1 MC1536 A1 MC 1536A1
Authority
MC
Monaco
Prior art keywords
hydrogen
alkyl
group
hydroxy
phenyl
Prior art date
Application number
MC831652A
Other languages
English (en)
French (fr)
Inventor
Leo Alig
Marcel Mueller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1536A1 publication Critical patent/MC1536A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Battery Electrode And Active Subsutance (AREA)
MC831652A 1982-08-10 1983-08-09 Nouvelles phenethanolamines MC1536A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH478782 1982-08-10
CH289783 1983-05-27

Publications (1)

Publication Number Publication Date
MC1536A1 true MC1536A1 (fr) 1984-05-25

Family

ID=25691672

Family Applications (1)

Application Number Title Priority Date Filing Date
MC831652A MC1536A1 (fr) 1982-08-10 1983-08-09 Nouvelles phenethanolamines

Country Status (18)

Country Link
US (1) US4585796A (cs)
EP (1) EP0101069B1 (cs)
AU (1) AU570640B2 (cs)
CA (1) CA1258454A (cs)
CS (1) CS240972B2 (cs)
DE (1) DE3363177D1 (cs)
DK (1) DK350083A (cs)
ES (1) ES8505333A1 (cs)
FI (1) FI80030C (cs)
HU (1) HU191867B (cs)
IE (1) IE55896B1 (cs)
IL (1) IL69438A (cs)
MC (1) MC1536A1 (cs)
NO (1) NO832867L (cs)
NZ (1) NZ205132A (cs)
PH (1) PH18647A (cs)
PT (1) PT77173B (cs)
ZW (1) ZW15483A1 (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds
PT82120B (en) * 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives
NZ215753A (en) * 1985-04-16 1989-10-27 Hoffmann La Roche Phenethanolamine derivatives and pharmaceutical compositions
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
DE3718638A1 (de) * 1987-06-04 1988-12-22 Thomae Gmbh Dr K Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FI892341A7 (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
ES2256370T3 (es) * 1991-08-23 2006-07-16 Nps Pharmaceuticals, Inc. Moleculas activas para el receptor de calcio.
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
ATE359259T1 (de) 1994-10-21 2007-05-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
DE69739388D1 (de) * 1996-05-01 2009-06-10 Nps Pharma Inc Inorganische am Ionen-Rezeptor aktive Verbindungen
WO2005028438A1 (ja) 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
EP2330124B1 (en) 2005-08-11 2015-02-25 Amylin Pharmaceuticals, LLC Hybrid polypeptides with selectable properties
JP2009512715A (ja) 2005-10-21 2009-03-26 ノバルティス アクチエンゲゼルシャフト レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ
CA2770486C (en) 2006-09-22 2014-07-15 Merck Sharp & Dohme Corp. Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
JPWO2009154132A1 (ja) 2008-06-19 2011-12-01 Ｍｓｄ株式会社 スピロジアミン−ジアリールケトオキシム誘導体
CA2741644C (en) 2008-10-30 2013-05-07 Merck Sharp & Dohme Corp. Isonicotinamide orexin receptor antagonists
EP2379562A1 (en) 2008-12-16 2011-10-26 Schering Corporation Bicyclic pyranone derivatives as nicotinic acid receptor agonists
WO2010075068A1 (en) 2008-12-16 2010-07-01 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AR088352A1 (es) 2011-10-19 2014-05-28 Merck Sharp & Dohme Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
MX2015001500A (es) 2012-08-02 2015-04-08 Merck Sharp & Dohme Compuestos antidiabeticos triciclicos.
WO2020223224A1 (en) 2019-04-29 2020-11-05 Ecolab Usa Inc. Oxygenated aminophenol compounds and methods for preventing monomer polymerization
CN113784992A (zh) 2019-04-29 2021-12-10 埃科莱布美国股份有限公司 氧化芳香胺和作为抗氧化剂的用途
US11767393B2 (en) 2020-10-21 2023-09-26 Ecolab Usa Inc. (Hydroxyalkyl)aminophenol polymers and methods of use

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD45721A (cs) *
GB1109924A (en) * 1965-11-29 1968-04-18 Roche Products Ltd Novel substituted diphenylalkyl amines and a process for the manufacture thereof
US3732300A (en) * 1966-09-23 1973-05-08 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US4101579A (en) * 1969-02-06 1978-07-18 Allen & Hanburys Limited Phenethanolamine ethers
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2023829C3 (de) * 1970-05-15 1979-06-21 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
US3867455A (en) * 1970-06-02 1975-02-18 Allen & Hanburys Ltd Preparation of phenylaminoethanols
US4137328A (en) * 1970-07-18 1979-01-30 Pfizer Inc. Phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives as heart stimulants
GB1394001A (en) * 1972-12-22 1975-05-14 Pfizer Ltd 2-morpholino or homomorpholino 1-3-trifluoromethylphenyl propanes
CA1145766A (en) * 1978-07-03 1983-05-03 Jack Mills Optically active phenethanolamines and method for increasing cardiac contractility
CA1120058A (en) * 1978-07-03 1982-03-16 Jack Mills Phenethanolamines, formulations and potentiation of oncolytic drugs
CA1145767A (en) * 1978-07-03 1983-05-03 Jack Mills Phenethanolamines, compositions containing the same, and method for effecting weight control
US4338333A (en) * 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
EP0028105B1 (en) * 1979-10-25 1983-01-19 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
DE3070865D1 (en) * 1979-11-15 1985-08-14 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
EP0040000B1 (en) * 1980-05-08 1983-10-12 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
EP0040915B1 (en) * 1980-05-22 1984-03-21 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
GB2084577B (en) * 1980-09-26 1984-05-02 Beecham Group Ltd Secondary amines
DE3264364D1 (en) * 1981-03-06 1985-08-01 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
DE3260490D1 (en) * 1981-03-31 1984-09-06 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0063004A1 (en) * 1981-04-09 1982-10-20 Beecham Group Plc Secondary amines, processes for their preparation, and pharmaceutical compositions containing them
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
DE3267406D1 (en) * 1981-07-11 1985-12-19 Beecham Group Plc Secondary phenyl ethanol amines and their pharmaceutical use
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines

Also Published As

Publication number Publication date
DE3363177D1 (de) 1986-05-28
FI80030B (fi) 1989-12-29
PH18647A (en) 1985-08-23
IL69438A0 (en) 1983-11-30
DK350083A (da) 1984-02-11
IE55896B1 (en) 1991-02-14
PT77173A (en) 1983-09-01
IE831872L (en) 1984-02-10
NZ205132A (en) 1987-03-06
ES524823A0 (es) 1985-06-01
PT77173B (en) 1986-03-20
US4585796A (en) 1986-04-29
FI80030C (fi) 1990-04-10
NO832867L (no) 1984-02-13
ZW15483A1 (en) 1985-01-30
AU1758883A (en) 1984-02-16
DK350083D0 (da) 1983-07-29
HU191867B (en) 1987-04-28
FI832844A7 (fi) 1984-02-11
CS240972B2 (en) 1986-03-13
CA1258454A (en) 1989-08-15
FI832844A0 (fi) 1983-08-08
EP0101069B1 (de) 1986-04-23
EP0101069A1 (de) 1984-02-22
IL69438A (en) 1986-08-31
AU570640B2 (en) 1988-03-24
ES8505333A1 (es) 1985-06-01
CS586083A2 (en) 1985-06-13

Similar Documents

Publication Publication Date Title
MC1536A1 (fr) Nouvelles phenethanolamines
DK168761B1 (da) Phenylethere og farmaceutisk acceptable salte deraf, fremgangsmåder til fremstilling heraf samt far maceutiske midler indeholdelde disse
MC1625A1 (fr) Procede de preparation de phenoxypropanolamines
MC1831A1 (fr) Derives de pyridine-ethalolamine
FR2460919A1 (fr) Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique
MC1516A1 (fr) Nouveaux derives d'aziridine et de phenethanolamine
MC1641A1 (fr) Oxazolidines
MC1744A1 (fr) Derives de phenylethanolamines
WO1997006136A1 (fr) Derives de benzenesulfonamide, leur preparation et leurs applications en therapeutique
EP0037344B1 (fr) Amino-alcoxy pyrazoles, procédé pour leur préparation, et médicaments les contenant
MC2042A1 (fr) Derives de propanolamine
CA2036920A1 (fr) Sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2653767A1 (fr) Derives de 1-(aminophenyl)-2-piperidinopropanone, procede et utilisation en therapeutique.
FR2470110A1 (fr) Derives de la decrapenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
CH682322A5 (cs)
FR2484407A1 (fr) Derives de la nonaprenylamine, leurs sels acides d'addition et composition pharmaceutique les renfermant
FR2726268A1 (fr) Nouvelles o-arylmethyl n-(thio)acyl hydroxylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent
FR2507180A1 (fr) Nouvelles phenylalkylamines, leur preparation et leur application comme medicaments
EP0244318A1 (fr) Nouveaux dérivés de la N-[(triméthoxy-2,4,6-benzoyl)-3 propyl] pipéridine, leurs procédés de préparation et leur application en thérapeutique
FR2470111A1 (fr) Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits
EP0226475A1 (fr) Nouveaux dérivés de la diphénoxyethylamine, leur procédé d'obtention et les compositions pharmaceutiques en renfermant
KR820001300B1 (ko) 펜에탄올아민 유도체의 제조방법
EP0174887B1 (fr) Dérivés de 1-[N-(alpha-amino-alpha-méthylacétyl)-aminophényl]-2-amino-propanone, procédé de préparation et utilisation en thérapeutique
EP0110748A1 (fr) Dérivés de phényl-(3-aminopropyl)-cétone, utilisation en thérapeutique et procédé de préparation

Legal Events

Date Code Title Description
YP Annual fee paid